APA-referens (7:e uppl.)

Lv, F., Si, W., Xu, X., He, X., Wang, Y., Li, Y., & Li, F. (2024). RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells. Elsevier.

Chicago-referens (17:e uppl.)

Lv, Fengxu, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, och Feifei Li. RUNX2 Prompts Triple Negative Breast Cancer Drug Resistance Through TGF-β Pathway Regulating Breast Cancer Stem Cells. Elsevier, 2024.

MLA-referens (9:e uppl.)

Lv, Fengxu, et al. RUNX2 Prompts Triple Negative Breast Cancer Drug Resistance Through TGF-β Pathway Regulating Breast Cancer Stem Cells. Elsevier, 2024.